BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32532752)

  • 1. Bacterial citrullinated epitopes generated by
    Jenning M; Marklein B; Ytterberg J; Zubarev RA; Joshua V; van Schaardenburg D; van de Stadt L; Catrina AI; Nonhoff U; Häupl T; Konthur Z; Burmester GR; Skriner K
    Ann Rheum Dis; 2020 Sep; 79(9):1194-1202. PubMed ID: 32532752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis.
    Quirke AM; Lugli EB; Wegner N; Hamilton BC; Charles P; Chowdhury M; Ytterberg AJ; Zubarev RA; Potempa J; Culshaw S; Guo Y; Fisher BA; Thiele G; Mikuls TR; Venables PJ
    Ann Rheum Dis; 2014 Jan; 73(1):263-9. PubMed ID: 23463691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the role of Porphyromonas gingivalis peptidylarginine deiminase (PPAD) in rheumatoid arthritis through the study of PPAD biology.
    Konig MF; Paracha AS; Moni M; Bingham CO; Andrade F
    Ann Rheum Dis; 2015 Nov; 74(11):2054-61. PubMed ID: 24864075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periodontal sources of citrullinated antigens and TLR agonists related to RA.
    Vitkov L; Hannig M; Minnich B; Herrmann M
    Autoimmunity; 2018 Sep; 51(6):304-309. PubMed ID: 30417696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking, Porphyromonas gingivalis and the immune response to citrullinated autoantigens before the clinical onset of rheumatoid arthritis in a Southern European nested case-control study.
    Fisher BA; Cartwright AJ; Quirke AM; de Pablo P; Romaguera D; Panico S; Mattiello A; Gavrila D; Navarro C; Sacerdote C; Vineis P; Tumino R; Lappin DF; Apatzidou D; Culshaw S; Potempa J; Michaud DS; Riboli E; Venables PJ
    BMC Musculoskelet Disord; 2015 Nov; 16():331. PubMed ID: 26537917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porphyromonas gulae and PPAD antibodies are not related to citrullination in rheumatoid arthritis.
    Castellar-Mendoza C; Castillo DM; Chila-Moreno L; Bautista-Molano W; Romero-Sánchez C
    Clin Oral Investig; 2023 Jul; 27(7):3509-3519. PubMed ID: 37133700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of Porphyromonas gingivalis peptidylarginine deiminase: implications for autoimmunity in rheumatoid arthritis.
    Montgomery AB; Kopec J; Shrestha L; Thezenas ML; Burgess-Brown NA; Fischer R; Yue WW; Venables PJ
    Ann Rheum Dis; 2016 Jun; 75(6):1255-61. PubMed ID: 26209657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase.
    Lundberg K; Kinloch A; Fisher BA; Wegner N; Wait R; Charles P; Mikuls TR; Venables PJ
    Arthritis Rheum; 2008 Oct; 58(10):3009-19. PubMed ID: 18821669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of anti-Porphyromonas gingivalis peptidylarginine deiminase immunoglobulin G and peptidylarginine deiminase-4 in patients with rheumatoid arthritis and periodontitis.
    Shimada A; Kobayashi T; Ito S; Okada M; Murasawa A; Nakazono K; Yoshie H
    J Periodontal Res; 2016 Feb; 51(1):103-11. PubMed ID: 26094771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to a Citrullinated
    Sherina N; de Vries C; Kharlamova N; Sippl N; Jiang X; Brynedal B; Kindstedt E; Hansson M; Mathsson-Alm L; Israelsson L; Stålesen R; Saevarsdottir S; Holmdahl R; Hensvold A; Johannsen G; Eriksson K; Sallusto F; Catrina AI; Rönnelid J; Grönwall C; Yucel-Lindberg T; Alfredsson L; Klareskog L; Piccoli L; Malmström V; Amara K; Lundberg K
    Front Immunol; 2022; 13():804822. PubMed ID: 35514991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different Hierarchies of Anti-Modified Protein Autoantibody Reactivities in Rheumatoid Arthritis.
    Sahlström P; Hansson M; Steen J; Amara K; Titcombe PJ; Forsström B; Stålesen R; Israelsson L; Piccoli L; Lundberg K; Klareskog L; Mueller DL; Catrina AI; Skriner K; Malmström V; Grönwall C
    Arthritis Rheumatol; 2020 Oct; 72(10):1643-1657. PubMed ID: 32501655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies From Single Circulating Plasmablasts React With Citrullinated Antigens and Porphyromonas gingivalis in Rheumatoid Arthritis.
    Li S; Yu Y; Yue Y; Liao H; Xie W; Thai J; Mikuls TR; Thiele GM; Duryee MJ; Sayles H; Payne JB; Klassen LW; O'Dell JR; Zhang Z; Su K
    Arthritis Rheumatol; 2016 Mar; 68(3):614-26. PubMed ID: 26474325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential ACPA Binding to Nuclear Antigens Reveals a PAD-Independent Pathway and a Distinct Subset of Acetylation Cross-Reactive Autoantibodies in Rheumatoid Arthritis.
    Lloyd KA; Wigerblad G; Sahlström P; Garimella MG; Chemin K; Steen J; Titcombe PJ; Marklein B; Zhou D; Stålesen R; Ossipova E; Lundqvist C; Ekwall O; Rönnelid J; Mueller DL; Karlsson MCI; Kaplan MJ; Skriner K; Klareskog L; Wermeling F; Malmström V; Grönwall C
    Front Immunol; 2018; 9():3033. PubMed ID: 30662440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citrullination in the periodontium--a possible link between periodontitis and rheumatoid arthritis.
    Laugisch O; Wong A; Sroka A; Kantyka T; Koziel J; Neuhaus K; Sculean A; Venables PJ; Potempa J; Möller B; Eick S
    Clin Oral Investig; 2016 May; 20(4):675-83. PubMed ID: 26264638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses to de novo identified citrullinated fibrinogen peptides in rheumatoid arthritis and visualization of the corresponding B cells.
    Joshua V; Schobers L; Titcombe PJ; Israelsson L; Rönnelid J; Hansson M; Catrina AI; Pruijn GJ; Malmström V
    Arthritis Res Ther; 2016 Dec; 18(1):284. PubMed ID: 27906052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration of antibodies against Porphyromonas gingivalis is increased before the onset of symptoms of rheumatoid arthritis.
    Johansson L; Sherina N; Kharlamova N; Potempa B; Larsson B; Israelsson L; Potempa J; Rantapää-Dahlqvist S; Lundberg K
    Arthritis Res Ther; 2016 Sep; 18(1):201. PubMed ID: 27605245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinity purified anti-citrullinated protein/peptide antibodies target antigens expressed in the rheumatoid joint.
    Ossipova E; Cerqueira CF; Reed E; Kharlamova N; Israelsson L; Holmdahl R; Nandakumar KS; Engström M; Harre U; Schett G; Catrina AI; Malmström V; Sommarin Y; Klareskog L; Jakobsson PJ; Lundberg K
    Arthritis Res Ther; 2014 Aug; 16(4):R167. PubMed ID: 25112157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis.
    Schwenzer A; Jiang X; Mikuls TR; Payne JB; Sayles HR; Quirke AM; Kessler BM; Fischer R; Venables PJ; Lundberg K; Midwood KS
    Ann Rheum Dis; 2016 Oct; 75(10):1876-83. PubMed ID: 26659718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure, function, and inhibition of a genomic/clinical variant of Porphyromonas gingivalis peptidylarginine deiminase.
    Bereta G; Goulas T; Madej M; Bielecka E; Solà M; Potempa J; Gomis-Rüth FX
    Protein Sci; 2019 Mar; 28(3):478-486. PubMed ID: 30638292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Citrulline Not a Major Determinant in the Recognition of Peptidylarginine Deiminase 2 and 4 by Autoantibodies in Rheumatoid Arthritis.
    Darrah E; Davis RL; Curran AM; Naik P; Chen R; Na CH; Giles JT; Andrade F
    Arthritis Rheumatol; 2020 Sep; 72(9):1476-1482. PubMed ID: 32255561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.